Abstract:Aims: To investigate the relationship between N-terminal pro-B-type natriuretic peptide (NT-proBNP), Glomerular Filtration Rate (GFR), and outcomes in patients hospitalized with acute heart failure (AHF). Methods: The trial was registered at http://www.chictr.org/cn/. (ChiCTR - ONC - 12001944). A total of 493 patients hospitalized for AHF in cardiology department of the First Affiliated Hospital of Nanjing Medical University from March 2012 to October 2016 were enrolled into registry. The end event was the occurrence of all-cause death within an 18-month follow-up. The data collected from the participants in admission were used to calculate the GFR by chronic kidney disease epidemiology collaboration equation (CKD-EPI) and performed the according statistical analysis. Results: There were 74 participants (13.8%) dropped out and 91 (21.7%) passed away within the 18-month follow up. Comparison of clinical indicators between survival and death group were analyzed for the long-term prognosis of patients with AHF. In the single factor analysis, both NT-proBNP and GFR were statistically significant (P < 0.001). Combined NT-proBNP and GFR in multi-factor COX regression analysis showed significant predictive value (P < 0.001). In receiver operator characteristics (ROC) analyses, the area under the curves (AUC) for NT-proBNP was 0.648 [95%CI: 0.598-0.695, P < 0.001] and for GFR was 0.677 [95%CI: 0.627-0.723, P < 0.001]. According to the Youden index, the best prediction point of NT-proBNP was 2,137 pg/ml and GFR was 61.7 ml/(min·1.73 m2). After using the Binary Logistic Regression to combine the two indicators, the AUC was 0.711, which was significantly compared to the AUC of either single factor. The sensitivity of the combined indicators were 0.535, the specificity were 0.853. According to the cut-off point, these two indexes were separated into four groups for further analysis by Kaplan-Meier survival curve comparison (log-rank test), which showed that patients in the group with higher NT-proBNP and lower GFR had the worst prognosis. Conclusions: In patients with NT-proBNP > 2,137 pg/ml and GFR < 61.7 ml/(min·1.73 m2), the risk of death was significantly higher. The combination of GFR and NT-proBNP improved the predictive value for the long-term prognosis of AHF patients.

[Combination of B-type Brain Natriuretic Peptide with Left Ventricular Diastolic Dysfunction for Prediction of Mortality in the Patients with Septic Shock].

Multi-biomarker Strategy for Prediction of Myocardial Dysfunction and Mortality in Sepsis

Prognostic Value of B-type Natriuretic Peptide (BNP) and Its Potential Role in Guiding Fluid Therapy in Critically Ill Septic Patients

The predictive values of B-type natriuretic peptide for the heart function and prognosis in patients with severe sepsis and septic shock

Predictive Value of N-terminal Pro-Brain Natriuretic Peptide in Combination with the Sequential Organ Failure Assessment Score in Sepsis.

Differential Diagnoses Value of Plasama Brain Natriuretic in Patients with Acute Heart Failure

Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock]

The Value of Serum N-terminal Pro Brain Natriuretic Peptide in Predicting Left Ventricular Diastolic Dysfunction in Septic Shock Patients

[The Prognostic Value of N-terminal Pro-B-type Natriuretic Peptide in Patients with Severe Sepsis and Septic Shock].

Correlation Between Early Brain Natriuretic Peptide Level and Mortality in Cancer Patients with Septic Shock.

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and Glomerular Filtration Rate in Patients with Acute Heart Failure

Brain natriuretic peptide as a predictive marker of mortality in sepsis: an updated systematic review and meta-analysis

[Value explore and correlation analysis on pulmonary artery pressure and brain natriuretic peptide predicting prognosis in septic shock patients]

Correlation Between Brain Natriuretic Peptide Levels and the Prognosis of Patients with Left Ventricular Diastolic Dysfunction.

Clinical usefulness of NT-proBNP as a prognostic factor for septic shock patients presenting to the emergency department

Use of B-type Natriuretic Peptide in Evaluation of Early Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome.

B-type Natriuretic Peptides for Prediction of Weaning Failure from Mechanical Ventilation after Off-Pump Coronary Artery Bypass Grafting

The predictive value of N-terminal pro-brain natriuretic peptide on prognosis of sepsis

Prognostic value of N-terminal pro-brain natriuretic peptide in patients with sepsis

Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.

Brain Natriuretic Peptide and Cardiac Troponin I for Prediction of the Prognosis in Cancer Patients with Sepsis